ARMR Sciences CEO urges Congress to pursue experimental fentanyl vaccine
ARMR Sciences CEO Collin Gage told Fox News Digital the U.S. is approaching the fentanyl crisis all wrong and should prioritize prevention, including an experimental fentanyl vaccine now in a Phase 1/2 clinical trial, as a new Democrat-controlled Congress prepares to take office.
This is HUB News’s original summary. Read the complete report at Fox News.